Andrew Hill Investment Advisors, Inc. Abb Vie Inc. Transaction History

Andrew Hill Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$134.21 - $153.93 $954,367 - $1.09 Million	-7,111 Reduced 24.59%	21,806 $2.93 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $639,657 - $813,214	-4,648 Reduced 13.85%	28,917 $4.43 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $369,016 - $457,845	-2,796 Reduced 7.69%	33,565 $5.44 Million
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $3.91 Million - $4.94 Million	36,361 New	36,361 $4.92 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Andrew Hill Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Andrew Hill Investment Advisors, Inc. with notifications on news.